Castleark Management LLC Myriad Genetics Inc Transaction History

Castleark Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$24.13 - $32.63 $7.07 Million - $9.56 Million	-292,850 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $46,153 - $56,456	-1,540 Reduced 0.52%	292,850 $9.46 Million
Q2 2021 Aug 17, 2021	BUY	$25.39 - $32.61 $389,863 - $500,726	15,355 Added 5.5%	294,390 $9 Million
Q1 2021 May 14, 2021	BUY	$19.92 - $31.6 $5.56 Million - $8.82 Million	279,035 New	279,035 $8.5 Million
Q4 2020 Feb 17, 2021	SELL	$12.16 - $19.77 $2,918 - $4,744	-240 Closed	0 $0
Q3 2019 Nov 15, 2019	SELL	$22.08 - $47.08 $463,679 - $988,680	-21,000 Reduced 98.87%	240 $7,000
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $34,458 - $53,200	-1,520 Reduced 6.68%	21,240 $590,000
Q4 2017 Feb 15, 2018	SELL	$28.45 - $37.14 $12 Million - $15.7 Million	-422,875 Reduced 94.89%	22,760 $782,000
Q3 2017 Nov 15, 2017	BUY	$24.01 - $36.2 $10.7 Million - $16.1 Million	445,635	445,635 $16.1 Million

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.